Internalized Stigma Among People Who Inject Drugs

Cama, Elena; Brener, Loren; Wilson, Hannah; Hippel, Courtney von

doi:10.1080/10826084.2016.1188951

Cited by 57 publications

(38 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Frequent experience of discrimination was also associated with one out of two mental health indicators and all three wellbeing indicators. This builds upon previous research demonstrating an overall link between discrimination and mental and physical health (Couto e Cruz et al, Unpublished results;Young et al, 2005;Cama et al, 2016;Treloar et al, 2013).…”

Section: Discussionsupporting

confidence: 77%

“…Previous studies have found links between stigma, discrimination, and the health and wellbeing of people who use drugs (Cama et al, 2016;van Boekel et al, 2013) and have highlighted the importance of reducing discrimination in health and social care contexts (Brener et al, 2010;Neale et al, 2008). However, beyond this initial evidence, there is limited understanding of whether frequency of discrimination impacts the health, wellbeing, and welfare of PWID.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Frequent experience of discrimination among people who inject drugs: Links with health and wellbeing

Cruz

Salom

Dietze

et al. 2018

Drug and Alcohol Dependence

View full text Add to dashboard Cite

show abstract

Section: Discussionsupporting

confidence: 77%

Section: Introductionmentioning

confidence: 99%

Frequent experience of discrimination among people who inject drugs: Links with health and wellbeing

Cruz

Salom

Dietze

et al. 2018

Drug and Alcohol Dependence

View full text Add to dashboard Cite

show abstract

“…In this latter respect the literature takes two main forms (although see, for example, Room, 2005). One form comprises highly specific studies on stigmatising practices in particular settings such as drug treatment services, hospitals and workplaces, on how individuals cope with stigma, and meta-analyses of these bodies of work (Barratt, 2011;Cama et al, 2016;Hathaway, 2011;Keyes et al, 2010;Kulesza et al, 2013;Livingston et al, 2011;Luoma et al, 2007;Radcliffe and Stevens, 2008;Rivera et al, 2014, Simmonds andCoomber, 2009;Treloar and Holt, 2006). This work explores and documents experiences of stigma, and the operations of stigmatising perspectives, and considers the impact of stigma on individuals as well as ways of tackling it.…”

Section: Literature Reviewmentioning

confidence: 99%

Addiction stigma and the biopolitics of liberal modernity: A qualitative analysis

Fraser

Pienaar

Dilkes-Frayne

et al. 2017

International Journal of Drug Policy

130

122

View full text Add to dashboard Cite

Definitions of addiction have never been more hotly contested. The advance of neuroscientific accounts has not only placed into public awareness a highly controversial explanatory approach, it has also shed new light on the absence of agreement among the many experts who contest it. Proponents argue that calling addiction a 'brain disease' is important because it is destigmatising. Many critics of the neuroscientific approach also agree on this point. Considered from the point of view of the sociology of health and illness, the idea that labelling something a disease will alleviate stigma is a surprising one. Disease, as demonstrated in that field of research, is routinely stigmatised. In this article we take up the issue of stigma as it plays out in relation to addiction, seeking to clarify and challenge the claims made about the progress associated with disease models. To do so, we draw on Erving Goffman's classic work on stigma, reconsidering it in light of more recent, process oriented, theoretical resources, and posing stigmatisation as a performative biopolitical process. Analysing recently collected interviews conducted with 60 people in Australia who consider themselves to have an alcohol or other drug addiction, dependence or habit, we explore their accounts of stigma, finding experiences of stigma to be common, multiple and strikingly diverse. We argue that by treating stigma as politically productive - as a contingent biopolitically performative process rather than as a stable marker of some kind of anterior difference - we can better understand what it achieves. This allows us to consider not simply how the 'disease' of addiction can be destigmatised, or even whether the 'diseasing' of addiction is itself stigmatising (although this would seem a key question), but whether the very problematisation of 'addiction' in the first place constitutes a stigma process.

show abstract

“…Despite increased availability and promising results of such treatments, many patients report experiences of HCV-related stigma and discrimination (Brener et al, 2015, Harris, 2009Zickmund et al, 2003). The aetiology of such stigma is multifaceted but includes fear of infectiousness (Fraser and Treloar, 2006), social aversion to illness (Maynard, 2006), and an association with illicit drug injecting (Cama et al 2016;Paterson et al, 2006).…”

Section: Introductionmentioning

confidence: 99%

Experiences of diagnosis, stigma, culpability and disclosure in male patients with hepatitis C virus: An interpretative phenomenological analysis

et al. 2019

View full text Add to dashboard Cite

The current study aimed to explore the lived experience of patients with HCV infection. Semi-structured interviews were conducted with seven male participants living with HCV and were analysed using Interpretative Phenomenological Analysis (IPA). Two master themes were identified: (1) Diagnosis and the search for meaning, and (2) Impact of stigma on disclosure. Participants reported fears of contaminating others, feelings of stigma and concerns of disclosing the condition to others. Response to diagnosis, stigma and disclosure amongst the participants appeared to be interrelated and directly related to locus of blame for virus contraction. More specifically, HCV transmission via medical routes led to an externalisation of culpability and an openness to disclosure. Transmission of HCV as a direct result of intravenous drug use led to internalised blame and a fear of disclosure. The inter-and intra-personal consequences of HCV explored in the current study have potential implications for tailoring future psychological therapy and psychoeducation to the specific needs of the HCV population.

show abstract

Internalized Stigma Among People Who Inject Drugs

Cited by 57 publications

References 23 publications

Frequent experience of discrimination among people who inject drugs: Links with health and wellbeing

Frequent experience of discrimination among people who inject drugs: Links with health and wellbeing

Addiction stigma and the biopolitics of liberal modernity: A qualitative analysis

Experiences of diagnosis, stigma, culpability and disclosure in male patients with hepatitis C virus: An interpretative phenomenological analysis

Contact Info

Product

Resources

About